Request for Covid-19 Impact Assessment of this Report
Production, means the output of Nuclear Medicine-Radiopharmaceuticals
Revenue, means the sales value of Nuclear Medicine-Radiopharmaceuticals
This report studies Nuclear Medicine-Radiopharmaceuticals in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Cardinal Health, Inc (US)
GE Healthcare (UK)
Bracco Imaging S.p.A (Italy)
Nordion, Inc. (Canada)
Bayer HealthCare Medical Care (US)
Lantheus Medical Imaging Inc (US)
Advanced Medical Isotope Corporation (US)
Alliance Medical (UK)
Alseres Pharmaceuticals, Inc (US)
Avid Radiopharmaceuticals (US)
Actinium Pharmaceuticals Inc (US)
Ion Beam Applications S.A (Belgium)
Immunomedics, Inc. (US)
Jubilant Pharma (India)
Mallinckrodt Pharmaceuticals (Ireland)
Medi-Radiopharma Ltd (Hungary)
Peregrine Pharmaceuticals, Inc. (US)
Siemens Healthcare (US)
Positron Corporation (US)
Triad Isotopes, Inc. (US)
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Nuclear Medicine-Radiopharmaceuticals in these regions, from 2011 to 2021 (forecast) , like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
Type III
Split by application, this report focuses on consumption, market share and growth rate of Nuclear Medicine-Radiopharmaceuticals in each application, can be divided into
Diagnostic Applications: SPECT, PET.
Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
Application 3
Global Nuclear Medicine-Radiopharmaceuticals Market Research Report 2016
1 Nuclear Medicine-Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of Nuclear Medicine-Radiopharmaceuticals
1.2 Nuclear Medicine-Radiopharmaceuticals Segment by Type
1.2.1 Global Production Market Share of Nuclear Medicine-Radiopharmaceuticals by Type in 2015
1.2.2 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
1.2.3 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
1.2.4 Type III
1.3 Nuclear Medicine-Radiopharmaceuticals Segment by Application
1.3.1 Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Application in 2015
1.3.2 Diagnostic Applications: SPECT, PET.
1.3.3 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
1.3.4 Application 3
1.4 Nuclear Medicine-Radiopharmaceuticals Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Nuclear Medicine-Radiopharmaceuticals (2011-2021)
2 Global Nuclear Medicine-Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global Nuclear Medicine-Radiopharmaceuticals Production and Share by Manufacturers (2015 and 2016)
2.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Nuclear Medicine-Radiopharmaceuticals Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Nuclear Medicine-Radiopharmaceuticals Manufacturing Base Distribution, Sales Area and Product Type
2.5 Nuclear Medicine-Radiopharmaceuticals Market Competitive Situation and Trends
2.5.1 Nuclear Medicine-Radiopharmaceuticals Market Concentration Rate
2.5.2 Nuclear Medicine-Radiopharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Nuclear Medicine-Radiopharmaceuticals Production, Revenue (Value) by Region (2011-2016)
3.1 Global Nuclear Medicine-Radiopharmaceuticals Production and Market Share by Region (2011-2016)
3.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
4 Global Nuclear Medicine-Radiopharmaceuticals Supply (Production) , Consumption, Export, Import by Regions (2011-2016)
4.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption by Regions (2011-2016)
4.2 North America Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)
5 Global Nuclear Medicine-Radiopharmaceuticals Production, Revenue (Value) , Price Trend by Type
5.1 Global Nuclear Medicine-Radiopharmaceuticals Production and Market Share by Type (2011-2016)
5.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2011-2016)
5.3 Global Nuclear Medicine-Radiopharmaceuticals Price by Type (2011-2016)
5.4 Global Nuclear Medicine-Radiopharmaceuticals Production Growth by Type (2011-2016)
6 Global Nuclear Medicine-Radiopharmaceuticals Market Analysis by Application
6.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Application (2011-2016)
6.2 Global Nuclear Medicine-Radiopharmaceuticals Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Nuclear Medicine-Radiopharmaceuticals Manufacturers Profiles/Analysis
7.1 Cardinal Health, Inc (US)
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 GE Healthcare (UK)
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Bracco Imaging S.p.A (Italy)
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Nordion, Inc. (Canada)
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Bayer HealthCare Medical Care (US)
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Lantheus Medical Imaging Inc (US)
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Advanced Medical Isotope Corporation (US)
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Alliance Medical (UK)
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Alseres Pharmaceuticals, Inc (US)
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Avid Radiopharmaceuticals (US)
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Actinium Pharmaceuticals Inc (US)
7.12 Ion Beam Applications S.A (Belgium)
7.13 Immunomedics, Inc. (US)
7.14 Jubilant Pharma (India)
7.15 Mallinckrodt Pharmaceuticals (Ireland)
7.16 Medi-Radiopharma Ltd (Hungary)
7.17 Peregrine Pharmaceuticals, Inc. (US)
7.18 Siemens Healthcare (US)
7.19 Positron Corporation (US)
7.20 Triad Isotopes, Inc. (US)
8 Nuclear Medicine-Radiopharmaceuticals Manufacturing Cost Analysis
8.1 Nuclear Medicine-Radiopharmaceuticals Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Nuclear Medicine-Radiopharmaceuticals
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Nuclear Medicine-Radiopharmaceuticals Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Nuclear Medicine-Radiopharmaceuticals Market Forecast (2016-2021)
12.1 Global Nuclear Medicine-Radiopharmaceuticals Production, Revenue Forecast (2016-2021)
12.2 Global Nuclear Medicine-Radiopharmaceuticals Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Nuclear Medicine-Radiopharmaceuticals Production Forecast by Type (2016-2021)
12.4 Global Nuclear Medicine-Radiopharmaceuticals Consumption Forecast by Application (2016-2021)
12.5 Nuclear Medicine-Radiopharmaceuticals Price Forecast (2016-2021)
13 Research Findings and Conclusion
14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
Figure Picture of Nuclear Medicine-Radiopharmaceuticals
Figure Global Production Market Share of Nuclear Medicine-Radiopharmaceuticals by Type in 2015
Figure Product Picture of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
Table Major Manufacturers of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
Figure Product Picture of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
Table Major Manufacturers of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Application in 2015
Figure Diagnostic Applications: SPECT, PET. Examples
Figure Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Examples
Figure Application 3 Examples
Figure North America Nuclear Medicine-Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Nuclear Medicine-Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Nuclear Medicine-Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Nuclear Medicine-Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Nuclear Medicine-Radiopharmaceuticals Production of Key Manufacturers (2015 and 2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Production Share by Manufacturers (2015 and 2016)
Figure 2015 Nuclear Medicine-Radiopharmaceuticals Production Share by Manufacturers
Figure 2016 Nuclear Medicine-Radiopharmaceuticals Production Share by Manufacturers
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Nuclear Medicine-Radiopharmaceuticals Revenue Share by Manufacturers
Table 2016 Global Nuclear Medicine-Radiopharmaceuticals Revenue Share by Manufacturers
Table Global Market Nuclear Medicine-Radiopharmaceuticals Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Nuclear Medicine-Radiopharmaceuticals Average Price of Key Manufacturers in 2015
Table Manufacturers Nuclear Medicine-Radiopharmaceuticals Manufacturing Base Distribution and Sales Area
Table Manufacturers Nuclear Medicine-Radiopharmaceuticals Product Type
Figure Nuclear Medicine-Radiopharmaceuticals Market Share of Top 3 Manufacturers
Figure Nuclear Medicine-Radiopharmaceuticals Market Share of Top 5 Manufacturers
Table Global Nuclear Medicine-Radiopharmaceuticals Production by Regions (2011-2016)
Figure Global Nuclear Medicine-Radiopharmaceuticals Production and Market Share by Regions (2011-2016)
Figure Global Nuclear Medicine-Radiopharmaceuticals Production Market Share by Regions (2011-2016)
Figure 2015 Global Nuclear Medicine-Radiopharmaceuticals Production Market Share by Regions
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue by Regions (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Regions (2011-2016)
Table 2015 Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Regions
Table Global Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Table China Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Table India Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Market by Regions (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Regions (2011-2016)
Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Regions
Table North America Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table China Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table Japan Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table India Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Production by Type (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Production Share by Type (2011-2016)
Figure Production Market Share of Nuclear Medicine-Radiopharmaceuticals by Type (2011-2016)
Figure 2015 Production Market Share of Nuclear Medicine-Radiopharmaceuticals by Type
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue by Type (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Nuclear Medicine-Radiopharmaceuticals by Type (2011-2016)
Figure 2015 Revenue Market Share of Nuclear Medicine-Radiopharmaceuticals by Type
Table Global Nuclear Medicine-Radiopharmaceuticals Price by Type (2011-2016)
Figure Global Nuclear Medicine-Radiopharmaceuticals Production Growth by Type (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Consumption by Application (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Application (2011-2016)
Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Application in 2015
Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Growth Rate by Application (2011-2016)
Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption Growth Rate by Application (2011-2016)
Table Cardinal Health, Inc (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Figure Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Market Share (2011-2016)
Table GE Healthcare (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Figure GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Market Share (2011-2016)
Table Bracco Imaging S.p.A (Italy) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Market Share (2011-2016)
Table Nordion, Inc. (Canada) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Figure Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Market Share (2011-2016)
Table Bayer HealthCare Medical Care (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Market Share (2011-2016)
Table Lantheus Medical Imaging Inc (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Figure Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Market Share (2011-2016)
Table Advanced Medical Isotope Corporation (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Figure Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Market Share (2011-2016)
Table Alliance Medical (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Figure Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Market Share (2011-2016)
Table Alseres Pharmaceuticals, Inc (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Figure Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Market Share (2011-2016)
Table Avid Radiopharmaceuticals (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2011-2016)
Figure Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine-Radiopharmaceuticals
Figure Manufacturing Process Analysis of Nuclear Medicine-Radiopharmaceuticals
Figure Nuclear Medicine-Radiopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015
Table Major Buyers of Nuclear Medicine-Radiopharmaceuticals
Table Distributors/Traders List
Figure Global Nuclear Medicine-Radiopharmaceuticals Production and Growth Rate Forecast (2016-2021)
Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)
Table Global Nuclear Medicine-Radiopharmaceuticals Production Forecast by Regions (2016-2021)
Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Forecast by Regions (2016-2021)
Table Global Nuclear Medicine-Radiopharmaceuticals Production Forecast by Type (2016-2021)
Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Forecast by Application (2016-2021)
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...